Additionally, a 2007 law directed the agency to ensure that drug risk information appears "in a clear, conspicuous and ...

Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

UB neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication ...

Dr. Todd Ellerin, Vice Chair of Medicine at South Shore Health, talks to WCVB's Ed Harding about the effects popular ...

Biogen’s stock rose 1% Thursday, after Europe’s pharmaceutical regulator issued a positive opinion on the Alzheimer’s disease ...

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

At that time, Ilyang Pharmaceutical's stock price rose by more than 80,000 won in four months after distributing the press release, and a police investigation found that the treatment did not have a ...

Company behind weight loss drug Mounjaro, Lilly, has issued an official statement after British woman, Susan McGowan, died ...

Supreme Court dismisses plea mandating doctors to specify drug side effects, citing impracticality and existing regulations.

Ozempic (semaglutide) is a well-known prescription drug that’s used to treat blood sugar of people with type 2 diabetes, has ...